Digital transformation in the pharmaceutical industry is crucial for improved patient care, cost-effectiveness, greater transparency, improved production, and drug development.

Verdict has conducted a poll to assess by how much time the COVID-19 pandemic has accelerated the digital transformation of the pharmaceutical industry.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

COVID-19 accelerated digital transformation of the pharma industry by five years

Analysis of the poll results shows that COVID-19 has fast-forwarded digital transformation of the pharma industry by more than five years, as opined by a majority 35% of the respondents.

While 30% of the respondents voted that the pandemic accelerated digital transformation by more than six years, 5% voted that digital transformation was accelerated by five to six years.

Digital transformation of the pharma industry has been accelerated by two to three years and three to four years, according to 9% and 8% of the respondents, respectively.

Further, 8% of the respondents voted that digital transformation of the pharma industry has been accelerated by four to five years.

Approximately 27% of the respondents opined that COVID-19 has accelerated the digital transformation of the pharma sector by less than one year.

The analysis is based on 482 responses received from the readers of Pharmaceutical Technology, a Verdict network site, between 20 January and 01 March.

Impact of COVID-19 on digital transformation of the pharma industry

The COVID-19 pandemic impacted the pharmaceutical industry in many ways by delaying routine treatments, straining healthcare budgets, derailing drug development for non-COVID related diseases, and causing supply chain disruptions. The pharmaceutical industry was forced to adopt various digital technologies to overcome the challenges posed by the pandemic.

Technologies such as cloud computing and cybersecurity helped the industry adopt remote working and perform decentralised clinical trials, according to GlobalData. Companies need to adopt digital technologies according to the business needs and develop a robust digital transformation strategy before investing in new technologies, adds GlobalData.